

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.71642673 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 6.71642673 |
| 3 | proteasome assembly (GO:0043248) | 6.40896941 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.25376391 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 6.15331423 |
| 6 | ribosomal large subunit biogenesis (GO:0042273) | 6.02627790 |
| 7 | viral transcription (GO:0019083) | 5.81959625 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 5.77335730 |
| 9 | translational termination (GO:0006415) | 5.67598877 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 5.33175211 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.18838116 |
| 12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.07763592 |
| 13 | cotranslational protein targeting to membrane (GO:0006613) | 5.06416978 |
| 14 | protein targeting to ER (GO:0045047) | 5.01847288 |
| 15 | translational elongation (GO:0006414) | 4.97798520 |
| 16 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.96564103 |
| 17 | protein localization to endoplasmic reticulum (GO:0070972) | 4.78210247 |
| 18 | protein neddylation (GO:0045116) | 4.77591668 |
| 19 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.76231700 |
| 20 | respiratory electron transport chain (GO:0022904) | 4.62857719 |
| 21 | translational initiation (GO:0006413) | 4.62683762 |
| 22 | translation (GO:0006412) | 4.52891471 |
| 23 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.52761269 |
| 24 | * negative regulation of ligase activity (GO:0051352) | 4.52252743 |
| 25 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.52252743 |
| 26 | cellular protein complex disassembly (GO:0043624) | 4.52141607 |
| 27 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.51542613 |
| 28 | electron transport chain (GO:0022900) | 4.50195961 |
| 29 | viral life cycle (GO:0019058) | 4.47109256 |
| 30 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.43426602 |
| 31 | * regulation of cellular amino acid metabolic process (GO:0006521) | 4.39634950 |
| 32 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.35983288 |
| 33 | termination of RNA polymerase III transcription (GO:0006386) | 4.35983288 |
| 34 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.35420269 |
| 35 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.33714365 |
| 36 | cullin deneddylation (GO:0010388) | 4.32868627 |
| 37 | regulation of mitochondrial translation (GO:0070129) | 4.30050154 |
| 38 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.26076272 |
| 39 | respiratory chain complex IV assembly (GO:0008535) | 4.21969984 |
| 40 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.16932688 |
| 41 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.16834913 |
| 42 | GTP biosynthetic process (GO:0006183) | 4.12285941 |
| 43 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.07193897 |
| 44 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.07193897 |
| 45 | chaperone-mediated protein transport (GO:0072321) | 4.05319783 |
| 46 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.04605199 |
| 47 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.04605199 |
| 48 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.04605199 |
| 49 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.02165746 |
| 50 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.02165746 |
| 51 | cytochrome complex assembly (GO:0017004) | 4.01394009 |
| 52 | protein deneddylation (GO:0000338) | 3.99431348 |
| 53 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.97321648 |
| 54 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.96160865 |
| 55 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.94892547 |
| 56 | cellular component biogenesis (GO:0044085) | 3.94209894 |
| 57 | 7-methylguanosine mRNA capping (GO:0006370) | 3.91710431 |
| 58 | protein complex biogenesis (GO:0070271) | 3.90658047 |
| 59 | protein complex disassembly (GO:0043241) | 3.86612351 |
| 60 | 7-methylguanosine RNA capping (GO:0009452) | 3.84888377 |
| 61 | RNA capping (GO:0036260) | 3.84888377 |
| 62 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.84682795 |
| 63 | DNA deamination (GO:0045006) | 3.83075287 |
| 64 | * positive regulation of ligase activity (GO:0051351) | 3.81381170 |
| 65 | rRNA processing (GO:0006364) | 3.77153437 |
| 66 | UTP biosynthetic process (GO:0006228) | 3.73383465 |
| 67 | macromolecular complex disassembly (GO:0032984) | 3.70828229 |
| 68 | rRNA metabolic process (GO:0016072) | 3.69930693 |
| 69 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.69509038 |
| 70 | establishment of integrated proviral latency (GO:0075713) | 3.69196311 |
| 71 | formation of translation preinitiation complex (GO:0001731) | 3.69047525 |
| 72 | inner mitochondrial membrane organization (GO:0007007) | 3.64991145 |
| 73 | chromatin remodeling at centromere (GO:0031055) | 3.64938800 |
| 74 | CENP-A containing nucleosome assembly (GO:0034080) | 3.61052248 |
| 75 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.61012472 |
| 76 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.61012472 |
| 77 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.58859637 |
| 78 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.57981843 |
| 79 | pseudouridine synthesis (GO:0001522) | 3.54902982 |
| 80 | establishment of protein localization to mitochondrion (GO:0072655) | 3.54469377 |
| 81 | oxidative phosphorylation (GO:0006119) | 3.52956946 |
| 82 | protein targeting to mitochondrion (GO:0006626) | 3.52508827 |
| 83 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.52023431 |
| 84 | NADH dehydrogenase complex assembly (GO:0010257) | 3.52023431 |
| 85 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.52023431 |
| 86 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.51470696 |
| 87 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.50256835 |
| 88 | spliceosomal snRNP assembly (GO:0000387) | 3.49198293 |
| 89 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.43173098 |
| 90 | * regulation of ligase activity (GO:0051340) | 3.39915190 |
| 91 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.37118976 |
| 92 | peptidyl-histidine modification (GO:0018202) | 3.35530226 |
| 93 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.35529545 |
| 94 | * regulation of cellular amine metabolic process (GO:0033238) | 3.33577533 |
| 95 | protein targeting to membrane (GO:0006612) | 3.33071175 |
| 96 | DNA damage response, detection of DNA damage (GO:0042769) | 3.32529303 |
| 97 | protein localization to mitochondrion (GO:0070585) | 3.31674597 |
| 98 | * negative regulation of protein ubiquitination (GO:0031397) | 3.30746059 |
| 99 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.26910524 |
| 100 | * positive regulation of cell cycle arrest (GO:0071158) | 3.26777490 |
| 101 | establishment of viral latency (GO:0019043) | 3.24244848 |
| 102 | ATP biosynthetic process (GO:0006754) | 3.23426572 |
| 103 | spliceosomal complex assembly (GO:0000245) | 3.23344475 |
| 104 | rRNA modification (GO:0000154) | 3.21208536 |
| 105 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.20960834 |
| 106 | amino acid salvage (GO:0043102) | 3.18201668 |
| 107 | L-methionine salvage (GO:0071267) | 3.18201668 |
| 108 | L-methionine biosynthetic process (GO:0071265) | 3.18201668 |
| 109 | UTP metabolic process (GO:0046051) | 3.16873708 |
| 110 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.13828889 |
| 111 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.13679829 |
| 112 | hydrogen ion transmembrane transport (GO:1902600) | 3.12885764 |
| 113 | * negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.08726798 |
| 114 | purine nucleobase biosynthetic process (GO:0009113) | 3.05569215 |
| 115 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.04307645 |
| 116 | histone exchange (GO:0043486) | 3.01546815 |
| 117 | maturation of 5.8S rRNA (GO:0000460) | 3.00960126 |
| 118 | mitochondrial transport (GO:0006839) | 2.95607566 |
| 119 | rRNA methylation (GO:0031167) | 2.95170409 |
| 120 | intracellular protein transmembrane import (GO:0044743) | 2.93747635 |
| 121 | ribosome assembly (GO:0042255) | 2.93089032 |
| 122 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.92218410 |
| 123 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.92154789 |
| 124 | * signal transduction in response to DNA damage (GO:0042770) | 2.91569322 |
| 125 | * cell cycle G1/S phase transition (GO:0044843) | 2.91149741 |
| 126 | * G1/S transition of mitotic cell cycle (GO:0000082) | 2.91149741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.93496935 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.46768432 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.26857097 |
| 4 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.20165061 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.16336096 |
| 6 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.95339865 |
| 7 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.93738448 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.92178520 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.69721293 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.34772996 |
| 11 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.25304926 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.22974136 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.20769126 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.20308926 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.19542706 |
| 16 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.07303543 |
| 17 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.00809738 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.92327126 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.85186422 |
| 20 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.67830432 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.56957617 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.55402571 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.54529028 |
| 24 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.51262786 |
| 25 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.47342986 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.36162261 |
| 27 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.24431734 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.19294927 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13779021 |
| 30 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.09987163 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.07441871 |
| 32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.07215142 |
| 33 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.03967961 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.02565662 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.99238604 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.99113007 |
| 37 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.97456523 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93935955 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.82553625 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.76634725 |
| 41 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.71219034 |
| 42 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.68067764 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.66576345 |
| 44 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.64307602 |
| 45 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.63332228 |
| 46 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.61007443 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.60641674 |
| 48 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55899177 |
| 49 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.55353848 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53469235 |
| 51 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.45168996 |
| 52 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.45156269 |
| 53 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41409141 |
| 54 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38698495 |
| 55 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.37679504 |
| 56 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.37049623 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36655490 |
| 58 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.35354721 |
| 59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.33828477 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29611695 |
| 61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.23367161 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20290083 |
| 63 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.19489707 |
| 64 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.18624507 |
| 65 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17850396 |
| 66 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17394530 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16101710 |
| 68 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09447591 |
| 69 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.06052576 |
| 70 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.04634160 |
| 71 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.04214491 |
| 72 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.03620999 |
| 73 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03235906 |
| 74 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02423919 |
| 75 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01923489 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00805469 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98712083 |
| 78 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98354607 |
| 79 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.97878302 |
| 80 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93515429 |
| 81 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.93103717 |
| 82 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90781394 |
| 83 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90720823 |
| 84 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89718836 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.87013823 |
| 86 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.85190555 |
| 87 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.84095356 |
| 88 | EWS_26573619_Chip-Seq_HEK293_Human | 0.83957752 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.83943293 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81799461 |
| 91 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.80065020 |
| 92 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.79849108 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79587546 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79048891 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.78801446 |
| 96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.76600614 |
| 97 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.76081402 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.74956484 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.74684584 |
| 100 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.74383653 |
| 101 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.74324397 |
| 102 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73803528 |
| 103 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.73541644 |
| 104 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.73494009 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.73386189 |
| 106 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.70485886 |
| 107 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.69798629 |
| 108 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.69760788 |
| 109 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.68059413 |
| 110 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67918629 |
| 111 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.67619338 |
| 112 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.67619338 |
| 113 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.67619338 |
| 114 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.67434618 |
| 115 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.65292769 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.62738721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.37890001 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.76117970 |
| 3 | MP0008932_abnormal_embryonic_tissue | 3.48684085 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.42987787 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.40542683 |
| 6 | MP0010030_abnormal_orbit_morphology | 3.34291701 |
| 7 | MP0001529_abnormal_vocalization | 3.06900480 |
| 8 | MP0003077_abnormal_cell_cycle | 2.82454363 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.77298698 |
| 10 | MP0003186_abnormal_redox_activity | 2.70186898 |
| 11 | MP0006035_abnormal_mitochondrial_morpho | 2.66440444 |
| 12 | MP0003718_maternal_effect | 2.63652582 |
| 13 | MP0003315_abnormal_perineum_morphology | 2.63429985 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.53041514 |
| 15 | MP0008058_abnormal_DNA_repair | 2.41948599 |
| 16 | MP0001905_abnormal_dopamine_level | 2.39421519 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 2.39275404 |
| 18 | MP0003941_abnormal_skin_development | 2.05778307 |
| 19 | MP0003136_yellow_coat_color | 2.02014023 |
| 20 | MP0008877_abnormal_DNA_methylation | 1.95505820 |
| 21 | MP0003786_premature_aging | 1.84589507 |
| 22 | MP0004133_heterotaxia | 1.79892078 |
| 23 | MP0008057_abnormal_DNA_replication | 1.79497735 |
| 24 | MP0002751_abnormal_autonomic_nervous | 1.78518099 |
| 25 | MP0001727_abnormal_embryo_implantation | 1.77398070 |
| 26 | MP0000358_abnormal_cell_content/ | 1.66835634 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.64043365 |
| 28 | MP0002102_abnormal_ear_morphology | 1.60072291 |
| 29 | MP0003123_paternal_imprinting | 1.59080335 |
| 30 | MP0001188_hyperpigmentation | 1.55046921 |
| 31 | MP0004142_abnormal_muscle_tone | 1.54322950 |
| 32 | MP0008007_abnormal_cellular_replicative | 1.54179149 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.49121376 |
| 34 | MP0004147_increased_porphyrin_level | 1.47892260 |
| 35 | MP0009697_abnormal_copulation | 1.41553789 |
| 36 | MP0001730_embryonic_growth_arrest | 1.38946976 |
| 37 | MP0008260_abnormal_autophagy | 1.37830429 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.35782541 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.34975441 |
| 40 | MP0002938_white_spotting | 1.31859635 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.31481550 |
| 42 | MP0005499_abnormal_olfactory_system | 1.29075519 |
| 43 | MP0005394_taste/olfaction_phenotype | 1.29075519 |
| 44 | MP0002163_abnormal_gland_morphology | 1.28172287 |
| 45 | MP0000049_abnormal_middle_ear | 1.28128993 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.26942415 |
| 47 | MP0000750_abnormal_muscle_regeneration | 1.25935092 |
| 48 | MP0003195_calcinosis | 1.23163092 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.23019187 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.20177981 |
| 51 | MP0000749_muscle_degeneration | 1.15360945 |
| 52 | MP0001984_abnormal_olfaction | 1.14577792 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.14310170 |
| 54 | MP0001485_abnormal_pinna_reflex | 1.13314619 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.09734625 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.08972377 |
| 57 | MP0002234_abnormal_pharynx_morphology | 1.05514402 |
| 58 | MP0000350_abnormal_cell_proliferation | 1.04679877 |
| 59 | MP0002090_abnormal_vision | 1.02421815 |
| 60 | MP0003938_abnormal_ear_development | 1.01240367 |
| 61 | MP0005408_hypopigmentation | 1.00529670 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 0.99282999 |
| 63 | MP0008872_abnormal_physiological_respon | 0.98324527 |
| 64 | MP0001929_abnormal_gametogenesis | 0.98159339 |
| 65 | MP0002233_abnormal_nose_morphology | 0.95294006 |
| 66 | MP0001968_abnormal_touch/_nociception | 0.93470869 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 0.93312790 |
| 68 | MP0004742_abnormal_vestibular_system | 0.92723629 |
| 69 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92525923 |
| 70 | MP0003011_delayed_dark_adaptation | 0.92076970 |
| 71 | MP0003937_abnormal_limbs/digits/tail_de | 0.91799546 |
| 72 | MP0008995_early_reproductive_senescence | 0.91583517 |
| 73 | MP0000647_abnormal_sebaceous_gland | 0.90831999 |
| 74 | MP0002160_abnormal_reproductive_system | 0.90460561 |
| 75 | MP0003890_abnormal_embryonic-extraembry | 0.90216913 |
| 76 | MP0005266_abnormal_metabolism | 0.89374830 |
| 77 | MP0002210_abnormal_sex_determination | 0.89341524 |
| 78 | MP0005451_abnormal_body_composition | 0.89233188 |
| 79 | MP0001697_abnormal_embryo_size | 0.88963043 |
| 80 | MP0000313_abnormal_cell_death | 0.88919525 |
| 81 | MP0008789_abnormal_olfactory_epithelium | 0.85342729 |
| 82 | MP0005367_renal/urinary_system_phenotyp | 0.84882960 |
| 83 | MP0000516_abnormal_urinary_system | 0.84882960 |
| 84 | MP0002095_abnormal_skin_pigmentation | 0.84116317 |
| 85 | MP0005332_abnormal_amino_acid | 0.82627878 |
| 86 | MP0002080_prenatal_lethality | 0.82173088 |
| 87 | MP0005395_other_phenotype | 0.80168412 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.78526178 |
| 89 | MP0001764_abnormal_homeostasis | 0.78472628 |
| 90 | MP0002254_reproductive_system_inflammat | 0.78079966 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.78038493 |
| 92 | MP0001145_abnormal_male_reproductive | 0.77482018 |
| 93 | MP0003646_muscle_fatigue | 0.77445176 |
| 94 | MP0002148_abnormal_hypersensitivity_rea | 0.77054735 |
| 95 | MP0005389_reproductive_system_phenotype | 0.75928962 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 0.75758316 |
| 97 | MP0001853_heart_inflammation | 0.75338662 |
| 98 | MP0001293_anophthalmia | 0.74986464 |
| 99 | MP0005330_cardiomyopathy | 0.74739153 |
| 100 | MP0002132_abnormal_respiratory_system | 0.72893434 |
| 101 | MP0001119_abnormal_female_reproductive | 0.72374144 |
| 102 | MP0000026_abnormal_inner_ear | 0.72059869 |
| 103 | MP0005409_darkened_coat_color | 0.71157985 |
| 104 | MP0002736_abnormal_nociception_after | 0.71074230 |
| 105 | MP0005636_abnormal_mineral_homeostasis | 0.71072354 |
| 106 | MP0003121_genomic_imprinting | 0.69675559 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.68490884 |
| 108 | MP0001542_abnormal_bone_strength | 0.67474215 |
| 109 | MP0005410_abnormal_fertilization | 0.67226129 |
| 110 | MP0003880_abnormal_central_pattern | 0.67084885 |
| 111 | MP0000858_altered_metastatic_potential | 0.65972289 |
| 112 | MP0002111_abnormal_tail_morphology | 0.65083732 |
| 113 | MP0001672_abnormal_embryogenesis/_devel | 0.64754055 |
| 114 | MP0005380_embryogenesis_phenotype | 0.64754055 |
| 115 | MP0003942_abnormal_urinary_system | 0.63903967 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.63430674 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.62690504 |
| 118 | MP0002085_abnormal_embryonic_tissue | 0.62673817 |
| 119 | MP0001324_abnormal_eye_pigmentation | 0.62114399 |
| 120 | MP0002282_abnormal_trachea_morphology | 0.61523710 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60729867 |
| 122 | MP0001286_abnormal_eye_development | 0.60701552 |
| 123 | MP0000537_abnormal_urethra_morphology | 0.60279762 |
| 124 | MP0008873_increased_physiological_sensi | 0.60220708 |
| 125 | MP0009785_altered_susceptibility_to | 0.59974640 |
| 126 | MP0000653_abnormal_sex_gland | 0.59833826 |
| 127 | MP0004145_abnormal_muscle_electrophysio | 0.59436872 |
| 128 | MP0003119_abnormal_digestive_system | 0.58546205 |
| 129 | MP0003122_maternal_imprinting | 0.58500476 |
| 130 | MP0000613_abnormal_salivary_gland | 0.58173601 |
| 131 | MP0005253_abnormal_eye_physiology | 0.58021849 |
| 132 | MP0001919_abnormal_reproductive_system | 0.57592635 |
| 133 | MP0004381_abnormal_hair_follicle | 0.56338643 |
| 134 | MP0005248_abnormal_Harderian_gland | 0.55889635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Microvesicular hepatic steatosis (HP:0001414) | 6.40115283 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.08462735 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 5.66656115 |
| 4 | Mitochondrial inheritance (HP:0001427) | 5.24967265 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.10879153 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.67918094 |
| 7 | Acute encephalopathy (HP:0006846) | 4.56495717 |
| 8 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.51037123 |
| 9 | Increased CSF lactate (HP:0002490) | 4.48793695 |
| 10 | Progressive macrocephaly (HP:0004481) | 4.45066963 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 4.43499612 |
| 12 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.19342083 |
| 13 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.19342083 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 4.14575655 |
| 15 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 4.07823432 |
| 16 | Hepatic necrosis (HP:0002605) | 4.05137596 |
| 17 | Cerebral edema (HP:0002181) | 4.02099005 |
| 18 | Macrocytic anemia (HP:0001972) | 4.00379191 |
| 19 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.86048439 |
| 20 | Exercise intolerance (HP:0003546) | 3.85915878 |
| 21 | Increased serum pyruvate (HP:0003542) | 3.79187758 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.79187758 |
| 23 | Lipid accumulation in hepatocytes (HP:0006561) | 3.66242057 |
| 24 | Cerebral hypomyelination (HP:0006808) | 3.61107739 |
| 25 | Reticulocytopenia (HP:0001896) | 3.55837610 |
| 26 | Pallor (HP:0000980) | 3.48750323 |
| 27 | 3-Methylglutaconic aciduria (HP:0003535) | 3.47630311 |
| 28 | Increased serum lactate (HP:0002151) | 3.43689442 |
| 29 | Respiratory failure (HP:0002878) | 3.42218075 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 3.41380597 |
| 31 | Stenosis of the external auditory canal (HP:0000402) | 3.37723758 |
| 32 | Lactic acidosis (HP:0003128) | 3.34358452 |
| 33 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.19692497 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 3.15660151 |
| 35 | Birth length less than 3rd percentile (HP:0003561) | 3.13381525 |
| 36 | Abnormality of placental membranes (HP:0011409) | 3.11222680 |
| 37 | Amniotic constriction ring (HP:0009775) | 3.11222680 |
| 38 | Breast hypoplasia (HP:0003187) | 3.05519163 |
| 39 | Colon cancer (HP:0003003) | 2.96055057 |
| 40 | Increased intramyocellular lipid droplets (HP:0012240) | 2.95367961 |
| 41 | Exertional dyspnea (HP:0002875) | 2.94357144 |
| 42 | Leukodystrophy (HP:0002415) | 2.93878755 |
| 43 | Abnormality of the labia minora (HP:0012880) | 2.91580651 |
| 44 | Optic disc pallor (HP:0000543) | 2.81325793 |
| 45 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.71412962 |
| 46 | Progressive muscle weakness (HP:0003323) | 2.58819960 |
| 47 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.55278930 |
| 48 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.55278930 |
| 49 | Abnormal protein glycosylation (HP:0012346) | 2.55278930 |
| 50 | Abnormal glycosylation (HP:0012345) | 2.55278930 |
| 51 | Methylmalonic aciduria (HP:0012120) | 2.54681790 |
| 52 | Rough bone trabeculation (HP:0100670) | 2.52286739 |
| 53 | Parakeratosis (HP:0001036) | 2.50852542 |
| 54 | Abnormal hemoglobin (HP:0011902) | 2.44216639 |
| 55 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.41061157 |
| 56 | CNS demyelination (HP:0007305) | 2.38718514 |
| 57 | Abnormality of the anterior horn cell (HP:0006802) | 2.38456628 |
| 58 | Degeneration of anterior horn cells (HP:0002398) | 2.38456628 |
| 59 | Poor head control (HP:0002421) | 2.38191479 |
| 60 | Increased muscle lipid content (HP:0009058) | 2.38153467 |
| 61 | Oral leukoplakia (HP:0002745) | 2.36698759 |
| 62 | Methylmalonic acidemia (HP:0002912) | 2.35606412 |
| 63 | Emotional lability (HP:0000712) | 2.33054854 |
| 64 | Respiratory difficulties (HP:0002880) | 2.30066116 |
| 65 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.29287675 |
| 66 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27778352 |
| 67 | Abnormality of alanine metabolism (HP:0010916) | 2.27778352 |
| 68 | Hyperalaninemia (HP:0003348) | 2.27778352 |
| 69 | Carpal bone hypoplasia (HP:0001498) | 2.23208326 |
| 70 | Meckel diverticulum (HP:0002245) | 2.23017683 |
| 71 | Horseshoe kidney (HP:0000085) | 2.22269205 |
| 72 | Reduced antithrombin III activity (HP:0001976) | 2.22156288 |
| 73 | X-linked dominant inheritance (HP:0001423) | 2.19495211 |
| 74 | Hyperglycinemia (HP:0002154) | 2.18315950 |
| 75 | Hyperphosphaturia (HP:0003109) | 2.16161483 |
| 76 | Abnormality of serum amino acid levels (HP:0003112) | 2.15949743 |
| 77 | Sparse eyelashes (HP:0000653) | 2.15306159 |
| 78 | Generalized aminoaciduria (HP:0002909) | 2.14169749 |
| 79 | Trismus (HP:0000211) | 2.13605171 |
| 80 | Abnormality of the ileum (HP:0001549) | 2.11159613 |
| 81 | Congenital, generalized hypertrichosis (HP:0004540) | 2.07215540 |
| 82 | Abnormality of methionine metabolism (HP:0010901) | 2.06368988 |
| 83 | Septo-optic dysplasia (HP:0100842) | 2.05974977 |
| 84 | Abnormality of renal resorption (HP:0011038) | 2.03967786 |
| 85 | Abnormal trabecular bone morphology (HP:0100671) | 2.02618656 |
| 86 | Absent thumb (HP:0009777) | 1.96639766 |
| 87 | Patellar aplasia (HP:0006443) | 1.94849777 |
| 88 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.93828720 |
| 89 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.93446758 |
| 90 | Type 2 muscle fiber atrophy (HP:0003554) | 1.92737535 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89676354 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 1.89676354 |
| 93 | Poor suck (HP:0002033) | 1.89016101 |
| 94 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.88777418 |
| 95 | Testicular atrophy (HP:0000029) | 1.88529154 |
| 96 | Pancreatic cysts (HP:0001737) | 1.88470856 |
| 97 | Lethargy (HP:0001254) | 1.87978595 |
| 98 | CNS hypomyelination (HP:0003429) | 1.85458863 |
| 99 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.85448608 |
| 100 | Secondary amenorrhea (HP:0000869) | 1.85280166 |
| 101 | Progressive external ophthalmoplegia (HP:0000590) | 1.84604116 |
| 102 | Abnormal number of incisors (HP:0011064) | 1.84207302 |
| 103 | Abnormality of the preputium (HP:0100587) | 1.83558357 |
| 104 | Hypoplasia of the uterus (HP:0000013) | 1.83382815 |
| 105 | Pancreatic fibrosis (HP:0100732) | 1.82484802 |
| 106 | Aplasia of the musculature (HP:0100854) | 1.82360849 |
| 107 | Muscle fiber atrophy (HP:0100295) | 1.82247299 |
| 108 | Abnormality of the umbilical cord (HP:0010881) | 1.79491739 |
| 109 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.78884053 |
| 110 | Molar tooth sign on MRI (HP:0002419) | 1.77890122 |
| 111 | Abnormality of midbrain morphology (HP:0002418) | 1.77890122 |
| 112 | Aplastic anemia (HP:0001915) | 1.77690466 |
| 113 | Neoplasm of the adrenal gland (HP:0100631) | 1.77007501 |
| 114 | Cellular immunodeficiency (HP:0005374) | 1.76055459 |
| 115 | Irregular epiphyses (HP:0010582) | 1.75989505 |
| 116 | Hypoplasia of the pons (HP:0012110) | 1.75223540 |
| 117 | Hypoplasia of the radius (HP:0002984) | 1.73993048 |
| 118 | True hermaphroditism (HP:0010459) | 1.73553273 |
| 119 | Conical tooth (HP:0000698) | 1.72941175 |
| 120 | Hypoplastic pelvis (HP:0008839) | 1.72324781 |
| 121 | Prolonged neonatal jaundice (HP:0006579) | 1.71724408 |
| 122 | Absent septum pellucidum (HP:0001331) | 1.71339999 |
| 123 | Abnormality of urine glucose concentration (HP:0011016) | 1.70008204 |
| 124 | Glycosuria (HP:0003076) | 1.70008204 |
| 125 | Sclerocornea (HP:0000647) | 1.69167347 |
| 126 | Delusions (HP:0000746) | 1.68078887 |
| 127 | Abnormality of the pons (HP:0007361) | 1.67012918 |
| 128 | Abnormal urine phosphate concentration (HP:0012599) | 1.66760705 |
| 129 | Blindness (HP:0000618) | 1.66749939 |
| 130 | Pancytopenia (HP:0001876) | 1.64596221 |
| 131 | Abnormal lung lobation (HP:0002101) | 1.64565656 |
| 132 | Multiple enchondromatosis (HP:0005701) | 1.64426030 |
| 133 | Spastic paraparesis (HP:0002313) | 1.63767232 |
| 134 | Premature graying of hair (HP:0002216) | 1.62357394 |
| 135 | Postnatal microcephaly (HP:0005484) | 1.62335797 |
| 136 | Depressed nasal ridge (HP:0000457) | 1.62036627 |
| 137 | Facial cleft (HP:0002006) | 1.61903358 |
| 138 | Gliosis (HP:0002171) | 1.60103013 |
| 139 | Hypoplastic heart (HP:0001961) | 1.59720830 |
| 140 | Microretrognathia (HP:0000308) | 1.59339483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 6.40257992 |
| 2 | VRK2 | 5.14745295 |
| 3 | EIF2AK1 | 5.11310710 |
| 4 | NME2 | 3.66758648 |
| 5 | STK16 | 3.16289853 |
| 6 | EIF2AK3 | 3.04241069 |
| 7 | PBK | 2.89091271 |
| 8 | TLK1 | 2.76433932 |
| 9 | NME1 | 2.56537610 |
| 10 | WEE1 | 2.42695104 |
| 11 | PLK4 | 2.31850812 |
| 12 | TRIM28 | 2.22982111 |
| 13 | SRPK1 | 2.15959898 |
| 14 | NUAK1 | 2.08966174 |
| 15 | ARAF | 1.99301045 |
| 16 | PDK2 | 1.91495041 |
| 17 | PIM2 | 1.83727663 |
| 18 | TAF1 | 1.78483185 |
| 19 | VRK1 | 1.71873626 |
| 20 | RPS6KB2 | 1.71573370 |
| 21 | WNK3 | 1.61151151 |
| 22 | BRAF | 1.54666105 |
| 23 | MKNK1 | 1.50098911 |
| 24 | PNCK | 1.43816402 |
| 25 | CDC7 | 1.42025783 |
| 26 | TESK2 | 1.35949000 |
| 27 | DYRK2 | 1.35243885 |
| 28 | BRSK1 | 1.33773860 |
| 29 | ABL2 | 1.33356108 |
| 30 | MAP4K2 | 1.30311135 |
| 31 | LIMK1 | 1.27699970 |
| 32 | TSSK6 | 1.25326846 |
| 33 | ILK | 1.22114103 |
| 34 | AURKA | 1.21022677 |
| 35 | EPHA2 | 1.17867532 |
| 36 | MST4 | 1.15920777 |
| 37 | STK39 | 1.15244489 |
| 38 | MKNK2 | 1.14324259 |
| 39 | MAP3K12 | 1.13519079 |
| 40 | BMPR1B | 1.12999647 |
| 41 | BRSK2 | 1.12437090 |
| 42 | PLK1 | 1.09916942 |
| 43 | BCR | 1.07971510 |
| 44 | CSNK1G1 | 1.05458461 |
| 45 | TNIK | 1.02129826 |
| 46 | EIF2AK2 | 1.01677482 |
| 47 | IRAK3 | 1.00496165 |
| 48 | MAP3K11 | 1.00053598 |
| 49 | DAPK1 | 0.99700374 |
| 50 | PAK1 | 0.97052552 |
| 51 | PINK1 | 0.91835394 |
| 52 | ZAK | 0.90584235 |
| 53 | PLK3 | 0.90014088 |
| 54 | MUSK | 0.89845594 |
| 55 | CSNK1G2 | 0.88541726 |
| 56 | ACVR1B | 0.88053103 |
| 57 | CDK19 | 0.86286915 |
| 58 | GRK1 | 0.84145675 |
| 59 | AURKB | 0.82483595 |
| 60 | CASK | 0.81904391 |
| 61 | DYRK3 | 0.81112960 |
| 62 | KDR | 0.80609221 |
| 63 | CSNK1A1L | 0.79407986 |
| 64 | MYLK | 0.77851074 |
| 65 | MAP2K7 | 0.75181833 |
| 66 | TTK | 0.72571663 |
| 67 | CSNK2A1 | 0.71615554 |
| 68 | RPS6KA5 | 0.69928968 |
| 69 | IRAK4 | 0.69466192 |
| 70 | CDK7 | 0.68380093 |
| 71 | TESK1 | 0.65690400 |
| 72 | OBSCN | 0.65182530 |
| 73 | GRK7 | 0.64284394 |
| 74 | CSNK2A2 | 0.62655145 |
| 75 | ADRBK2 | 0.62579292 |
| 76 | INSRR | 0.60673915 |
| 77 | ERBB4 | 0.56682463 |
| 78 | OXSR1 | 0.55535223 |
| 79 | TIE1 | 0.55060337 |
| 80 | PRKCI | 0.55007383 |
| 81 | RPS6KA4 | 0.53925901 |
| 82 | CSNK1G3 | 0.52570435 |
| 83 | UHMK1 | 0.51809987 |
| 84 | CHEK2 | 0.51804780 |
| 85 | IRAK2 | 0.51565860 |
| 86 | CDK8 | 0.51507905 |
| 87 | EPHB2 | 0.49528912 |
| 88 | PAK4 | 0.48684714 |
| 89 | ROCK2 | 0.47210973 |
| 90 | MELK | 0.46318847 |
| 91 | STK38L | 0.46024040 |
| 92 | TGFBR1 | 0.44793265 |
| 93 | PRKCG | 0.44356232 |
| 94 | CDK14 | 0.44174395 |
| 95 | STK4 | 0.43414034 |
| 96 | WNK4 | 0.42740961 |
| 97 | PLK2 | 0.42605984 |
| 98 | TXK | 0.41933340 |
| 99 | DAPK3 | 0.41319453 |
| 100 | ATM | 0.39667751 |
| 101 | MINK1 | 0.39648174 |
| 102 | ADRBK1 | 0.37609770 |
| 103 | CSNK1A1 | 0.36273419 |
| 104 | PHKG2 | 0.36010009 |
| 105 | PHKG1 | 0.36010009 |
| 106 | NEK2 | 0.35920887 |
| 107 | BCKDK | 0.35558084 |
| 108 | MAP3K8 | 0.34995604 |
| 109 | STK10 | 0.34906953 |
| 110 | STK24 | 0.34875606 |
| 111 | CDK11A | 0.34845082 |
| 112 | PASK | 0.34629749 |
| 113 | CDK18 | 0.34267453 |
| 114 | MAPKAPK5 | 0.33116802 |
| 115 | NEK1 | 0.33022532 |
| 116 | CDK15 | 0.32583670 |
| 117 | ERBB3 | 0.31988719 |
| 118 | FRK | 0.31953726 |
| 119 | RPS6KC1 | 0.31868969 |
| 120 | RPS6KL1 | 0.31868969 |
| 121 | ATR | 0.31610527 |
| 122 | GRK5 | 0.31365313 |
| 123 | YES1 | 0.31229591 |
| 124 | CSNK1E | 0.29863842 |
| 125 | FGFR1 | 0.29258464 |
| 126 | EPHA4 | 0.28915225 |
| 127 | CAMK2B | 0.28382980 |
| 128 | IRAK1 | 0.27665262 |
| 129 | CHEK1 | 0.27061748 |
| 130 | CCNB1 | 0.27024380 |
| 131 | ALK | 0.26869966 |
| 132 | CAMK2G | 0.25834613 |
| 133 | PRKCD | 0.25433746 |
| 134 | LRRK2 | 0.25407036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.46372245 |
| 2 | * Proteasome_Homo sapiens_hsa03050 | 5.19945996 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.42778108 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.96063150 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.87160514 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.92688909 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.75594136 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.75100873 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.61299912 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.61259677 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.42981373 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.36855315 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.32607130 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.31359072 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 1.99381082 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.93116202 |
| 17 | RNA transport_Homo sapiens_hsa03013 | 1.83127011 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.62646966 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.53107882 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44135907 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40780395 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32533455 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32248813 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.27070917 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.25041287 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.24067613 |
| 27 | Purine metabolism_Homo sapiens_hsa00230 | 1.23303522 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.13966933 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04676591 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04559034 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02075052 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99607883 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94355365 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93615127 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93238924 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92348059 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.90339501 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87883163 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87278675 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81436915 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81081516 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79688966 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79417126 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77646946 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73352538 |
| 46 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72767803 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70912258 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70049538 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70000798 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68231742 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62888076 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61741059 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60473436 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.60053171 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59210712 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.57165825 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56157774 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55846476 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55402133 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54780307 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54566931 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52659415 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52579723 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50798993 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49947419 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49620593 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49570684 |
| 68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48454381 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47980096 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47595851 |
| 71 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47575330 |
| 72 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46627707 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45653185 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44489325 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44325733 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.43848746 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43077581 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42419870 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41492241 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41038667 |
| 81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.39480946 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39299992 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38869932 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38769493 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37673409 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35821592 |
| 87 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35413551 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33201378 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32880217 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30631183 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29655063 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.29654819 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.29414335 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29266766 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28608765 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.27467271 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.26491169 |
| 98 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.26053515 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.25345966 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25345229 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.24011526 |
| 102 | Asthma_Homo sapiens_hsa05310 | 0.23658583 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20422307 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.19919850 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.18598858 |
| 106 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.18212459 |
| 107 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.17404972 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.16798309 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15176259 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14664797 |
| 111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.14368421 |
| 112 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.13699030 |
| 113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.13655980 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.13609416 |
| 115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.12326303 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11158330 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10181023 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.10016279 |
| 119 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.08809353 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.07421295 |
| 121 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.06091859 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.05551612 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.04805007 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.04115568 |
| 125 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.03269327 |
| 126 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.02388160 |

